The health service of the Spanish region of Galicia has today (March 25 2003) agreed to provide access to positron emission tomography (PET) scanning within the region, in a deal with a private hospital. Hospital Modelo, in the city of A Coruna, is the only hospital in the region with these facilities. Until now, health service patients in Galicia have had to travel to the capital, Madrid, to gain access to these services.
Spanish region gets first access to PET (positron emission tomography):
The health service of the Spanish region of Galicia has today (March 25 2003) agreed to provide access to positron emission tomography (PET) scanning within the region, in a deal with a private hospital. Hospital Modelo, in the city of A Coruna, is the only hospital in the region with these facilities. Until now, health service patients in Galicia have had to travel to the capital, Madrid, to gain access to these services.
More from Archive
• By
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
• By
Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.
• By
Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.
• By
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.
More from Medtech Insight
• By
A panel of regulatory pros offered stakeholders tips for avoiding FDA citations after facility inspections. The July 29 webinar, hosted by ProPharma and Hyman Phelps and McNamara, follows the agency’s May announcement that it plans to up random foreign inspections.
• By
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
• By
Biostate AI has set up an Indian subsidiary, Bayosthiti, to develop cancer and cardiac diagnostics with local hospitals. This follows a joint venture with China's Kindstar Global and mirrors Biostate’s US collaboration with Mass General Brigham to build AI models for melanoma.